HomeTrading IdeasRate Cuts and Reality:...

Rate Cuts and Reality: Why Trump’s $600B Debt Savings Claim Falls Short

Last week, the Federal Reserve (), led by Chair Jerome Powell, announced its decision to keep the federal funds rate unchanged at 4.25–4.5%, marking the fourth consecutive meeting without a rate adjustment. Powell emphasized a cautious, data-driven approach, citing uncertainty over inflation, labor market trends, and the economic impact of President Donald Trump’s tariffs. Despite recent cooling in inflation, with core Personal Consumption Expenditures () at 2.5% in April, the Fed remains wary of persistent price pressures and is in no rush to cut rates, projecting only two potential reductions in 2025. 

Trump, however, sharply criticized Powell, branding him “Mr. Too Late” and a “numbskull” for not slashing rates. In posts on Truth Social, Trump argued that a 2% cut in the federal funds rate (to 2.25–2.5%) would save the government $600 billion annually in debt servicing costs, claiming the economy is thriving despite Powell’s inaction. Powell, of course, rebuffed Trump’s pressure, stressing the Fed’s independence and a focus on its dual mandate of price stability and maximum employment. He noted that tariffs could fuel inflation, complicating rate cuts (however, market-implied inflation expectations remain anchored and don’t foretell much higher inflation going forward). 

But while a lower rate could reduce interest on short-term Treasury bills (T-bill) and floating-rate notes (roughly 25% of the $28 trillion publicly held debt), most federal debt is locked in longer-term securities at fixed yields. That said, nearly $6 trillion of T-bill securities will need to be refinanced this year at or near the fed funds rate. So, a reduction in the fed funds rate would have a meaningful impact on U.S. debt service charges, but not perhaps to the degree that Trump suggested. 

While T-bills don’t have an interest rate, per se, they are issued at a discount to par (the discount reflects the effective yield), and the current effective yield is around 4.3%. So, by reducing the fed funds rate by 2%, the effective rate would likely fall to around 2.3%. Given the current T-bill composition, the likely savings would be in the range of $125 billion to $150 billion, not chump change, especially with deficits as large as they are, but shy of the $600 billion noted above. Moreover, market pricing suggests it would likely take an economic contraction or worse to get the fed funds rate much lower than 3.5%, which is what markets have priced in as the trough of the fed funds rate.

 Too Late Powell? 

 Nearly $6 trillion will need to be refinanced this year at/around the fed funds rate.

Source: LPL Research, Bloomberg 06/24/25

As for the coupon paying securities, which represent the lion’s share of Treasury issuance, the weighted average coupon for those securities is just under 2.9%. So, to get an actual reduction in debt service expenses for this $22 trillion, the U.S. Treasury yield curve would need to trade under 3%, which isn’t something we expect absent an economic contraction (which isn’t our base case). We think the Fed will cut rates this year and maybe a few times in 2026, but to get a meaningful reduction in U.S. interest expenses, the Fed would likely need to revisit the zero interest rate policies of the pre-COVID-19 years, which is unlikely to happen anytime soon, in our view.

 ***

Important Disclosures

This material is for general information only and is not intended to provide specific advice or recommendations for any individual. There is no assurance that the views or strategies discussed are suitable for all investors. To determine which investment(s) may be appropriate for you, please consult your financial professional prior to investing.

 Investing involves risks including possible loss of principal. No investment strategy or risk management technique can guarantee return or eliminate risk.

 

Most Popular

More from Author

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact...

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on...

Read Now

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact macroeconomic developments and policy events that could redefine short-term trends across currencies, commodities, and equities. Central banks once again take the spotlight, with both the Reserve Bank of Australia (RBA) and the Reserve Bank of New...

Trump’s New Tariffs Shake Markets as Yen and ETFs Slide – iShares MSCI Japan Index Fund (ARCA:EWJ), iShares MSCI Malaysia Index Fund (ARCA:EWM)

The U.S. dollar is notching its strongest one-day gain against the Japanese yen in nearly two months as traders react to President Donald Trump's sweeping new tariffs targeting multiple U.S. trading partners.Starting Aug. 1, all goods imported from Japan and other Asian trading partners will face a...

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk of the “death of U.S. exceptionalism.” Early 2025 saw a sharp shift in investor sentiment. Concerns over erratic trade policy, soaring debt, and weakening pressure challenged America’s long-standing market dominance. Markets fell sharply in April...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.What Happened?The company...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration deadline of July 9 approaches. However, President Trump adopted a confrontational stance once more by announcing that the US will begin issuing tariff...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the small resistance area on the H4 timeframe. but it is expected that the fundamental impulses can move the market more significantlyFigure 1. CAD/JPY...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges.A significant development contributing to this decline occurred in June 2025, when Novo Nordisk A/S...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs following a strong June, while technical signals in the broader market and semiconductor sector point to continued momentum. Meanwhile, recent policy developments may...

The Energy Report: Listen to What OPEC Says

prices are shaking off a larger-than-expected OPEC production increase as the precious metals get hit by a ton of bricks after President Trump posted about new tariffs on BRIC Nations on his Truth Social account. Yet despite the talk about OPEC wanting to maintain its market share,...

Why Is KalVista Pharmaceuticals Stock Soaring On Monday? – KalVista Pharma (NASDAQ:KALV)

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.Ekterly is the first and only oral on-demand treatment for HAE. HAE is characterized by recurrent...

Dow Jones Forecast: Political Tensions and Tariff Risks Weigh on Outlook

US futures are rising on Monday after the extended holiday weekend. Uncertainty surrounding U.S. trade tariff policies are keeping investors cautious, whilst Tesla (NASDAQ:) is taking a hit after Musk announced plans to launch a political party.US Futures 0.78% at 44839 0.7% at 6266 0.53% at 23977In...